Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
Spine (Phila Pa 1976). 2010 Aug 15;35(18):E908-11. doi: 10.1097/brs.0b013e3181dc57c1.
A report on 2 cases of subarachnoid pleural fistula (SAPF) treated with noninvasive positive pressure ventilation (NPPV).
To highlight the efficacy of NPPV in patients with SAPF.
SAPF is a rare but distressing type of cerebrospinal fluid leakage. It is known to be a complication of anterior thoracic spine surgery. The pressure gradient between the subarachnoid space and the pleural cavity maintains the cerebrospinal fluid leakage and precludes the spontaneous closure of the dura. Surgical interventions such as primary repair, patch grafts, muscle flaps, and omental flaps have been advocated. Only limited reports were found with reference to NPPV applied to SAPF.
Two patients, a 45-year-old woman and a 39-year-old woman, underwent anterior thoracic spine surgery to treat thoracic myelopathy caused by ossification of the posterior longitudinal ligament. After surgery, they developed SAPF due to perforation of the dura during surgery. Placement of thoracostomy tubes and subarachnoid drains had no effect and an NPPV device was applied.
During application of the NPPV device, 14 days in the first patient and 5 days in the second patient, the raised intrapleural pressure obstructed the fluid leakage and successfully treated the fistula. No recurrence of SAPF was observed after removal of the NPPV device and the patients avoided surgical interventions.
SAPF is often resistant to conservative therapies and has been treated in an invasive manner. NPPV should be considered as an alternative before such interventions because it is effective, noninvasive, and safe.
报告 2 例采用无创正压通气(NPPV)治疗的蛛网膜下腔胸腔瘘(SAPF)。
强调 NPPV 在 SAPF 患者中的疗效。
SAPF 是一种罕见但令人痛苦的脑脊液漏类型。已知它是前胸椎手术的并发症。蛛网膜下腔和胸腔之间的压力梯度维持着脑脊液漏,使硬脑膜无法自行闭合。已经提倡采用外科干预措施,如原发修复、补片移植、肌肉皮瓣和大网膜皮瓣。仅发现有限的报告提到将 NPPV 应用于 SAPF。
两名女性患者,年龄分别为 45 岁和 39 岁,因后纵韧带骨化导致胸段脊髓病而行前胸椎手术。手术后,由于手术过程中硬脑膜穿孔,她们发生 SAPF。放置胸腔引流管和蛛网膜下腔引流管均无效,并应用了 NPPV 装置。
在应用 NPPV 装置的过程中,第 1 例患者持续了 14 天,第 2 例患者持续了 5 天,升高的胸腔内压阻碍了液体漏出,并成功治疗了瘘管。在移除 NPPV 装置后,没有观察到 SAPF 的复发,并且患者避免了手术干预。
SAPF 通常对保守治疗有抵抗力,并且已经采用侵袭性方式进行治疗。在进行此类干预之前,应考虑将 NPPV 作为替代方法,因为它有效、无创且安全。